Guidelines of care for the management of atopic dermatitis in adults with topical therapies

BackgroundNew evidence has emerged since the 2014 guidelines that further informs the management of AD with topical therapies. These guidelines update the 2014 recommendations for management of atopic dermatitis (AD) with topical therapies.ObjectiveTo provide evidence-based recommendations related to management of AD in adults using topical treatments.MethodsA multidisciplinary workgroup conducted a systematic review and applied the …

Continue reading Guidelines of care for the management of atopic dermatitis in adults with topical therapies

Prenatal antibiotic exposure, asthma and the atopic march: A systematic review and meta-analysis

BackgroundAntibiotic use during pregnancy may increase the risk for asthma in children. We performed a meta-analysis assessing prenatal antibiotic exposure and the risk for childhood wheeze or asthma, as well as for diseases associated with the atopic march. MethodsA systematic literature search protocol (PROSPERO-ID: CRD42020191940) was registered and searches were completed using Medline, Proquest, Embase, …

Continue reading Prenatal antibiotic exposure, asthma and the atopic march: A systematic review and meta-analysis

Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)

Risk factors for severe COVID-19 include older age, male sex, obesity, black or Asian ethnicity and underlying medical conditions. Whether these factors also influence susceptibility to developing COVID-19 is uncertain. Methods We undertook a prospective, population-based cohort study (COVIDENCE UK) from 1 May 2020 to 5 February 2021. Baseline information on potential risk factors was …

Continue reading Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)

Assessment of #Allergic and #Anaphylactic Reactions to mRNA #COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System

Objective To characterize the immunologic mechanisms underlying allergic reactions to these vaccines. Design, Setting, and Participants This case series included 22 patients with suspected allergic reactions to mRNA COVID-19 vaccines between December 18, 2020, and January 27, 2021, at a large regional health care network. Participants were individuals who received at least 1 of the …

Continue reading Assessment of #Allergic and #Anaphylactic Reactions to mRNA #COVID-19 Vaccines With Confirmatory Testing in a US Regional Health System